Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$193K Buy
759
+619
+442% +$153K 0.05% 78
2020
Q2
$33K Buy
140
+42
+43% +$9.58K 0.01% 104
2020
Q1
$20K Buy
98
+15
+18% +$3.28K 0.01% 126
2019
Q4
$20K Sell
83
-9
-10% -$1.98K 0.01% 131
2019
Q3
$18K Hold
92
0.01% 144
2019
Q2
$17K Buy
92
+31
+51% +$5.55K 0.01% 151
2019
Q1
$12K Sell
61
-34
-36% -$6.49K ﹤0.01% 120
2018
Q4
$18K Hold
95
0.01% 113
2018
Q3
$20K Sell
95
-335
-78% -$66K 0.01% 111
2018
Q2
$80K Buy
+430
New +$76.1K 0.03% 89

Other funds holding AMGN

Price Wealth's AMGN Position: Q3 2020 in Review

Price Wealth increased its Amgen (AMGN) stake by 442% in Q3 2020, buying an estimated $153K and bringing the position to 759 shares worth $193K. The position accounts for 0.05% of the portfolio, ranked #78.

Price Wealth first reported a position in AMGN in Q2 2018 and has held it in 10 quarters since. 2,127 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Price Wealth held 759 shares of Amgen worth $193K as of Q3 2020.
  • Price Wealth bought 619 Amgen shares in Q3 2020, an estimated $153K.
  • Amgen made up 0.05% of Price Wealth's portfolio in Q3 2020, its #78 holding.
  • Price Wealth first reported a position in Amgen in Q2 2018 and has held it in 10 quarters since.
  • 2,127 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.